In a study on breast cancer, centrosome amplification was found to trigger cell invasion, a behavior similar to that induced by the overexpression of the breast cancer oncogene ErbB2, and it further enhanced ErbB2-induced invasiveness. Here, ERBB2 is linked to breast cancer.